FINWIRES · TerminalLIVE
FINWIRES

SHE:002019

4 stories mentioning SHE:002019Updated just now

Every FINWIRES story that references SHE:002019, newest first.

Treasury

Yifan Pharmaceutical Issues 500 Million Yuan in Senior Care Bonds

Yifan Pharmaceutical (SHE:002019) issued 500 million yuan of three-year elderly care bonds, according to a Thursday filing with the Shenzhen bourse.The bonds have an interest rate of 1.85% and will mature on Sept. 2, 2029.Industrial Bank is the bookrunner and lead underwriter, while the joint underwriters include CZBank, Bank of Ningbo, China Merchants Bank, Shanghai Pudong Development Bank, Bank of Communications, China Minsheng Bank, Hangzhou Bank, and CITIC Bank.

SHE:002019
Asia

Yifan Pharmaceutical Subsidiary Wins National Procurement Bid for Loquat Syrup

Yifan Pharmaceutical (SHE:002019) subsidiary Suzhou Yifan secured a winning bid for its Qiangli Pipalu (strong loquat syrup) in the national centralized procurement of Chinese patent medicines.The product, used for bronchitis-related cough, will be supplied under a procurement cycle running through Dec. 31, 2028, according to a Monday filing with the Shenzhen bourse.Shares of the pharmaceutical company climbed 1% in recent trade.

SHE:002019
Asia

Yifan Pharmaceutical Arm Gets China Nod for Anti-Itching Injection for Dialysis Patients

China's drug regulator granted Yifan Pharmaceutical (SHE:002019) subsidiary Hefei Yifan Biopharmaceutical marketing and production approval for its difenafine acetate injection.The drug helps treat moderate to severe pruritus or itching in hemodialysis patients, according to a Saturday filing with the Shenzhen bourse.

SHE:002019
Asia

Yifan Pharmaceutical Gets China Nod for Osteoporosis Biosimilar Trial

Yifan Pharmaceutical (SHE:002019) obtained Chinese regulatory approval to begin clinical trials for teriparatide injection.The drug, a biosimilar to Eli Lilly's Forteo, is indicated for treating osteoporosis in postmenopausal women at high fracture risk, according to a Thursday filing with the Shenzhen bourse.Shares of the pharmaceutical company closed 3% lower Thursday.

SHE:002019

Track with the FINWIRES app suite

FolioX
FolioX
Track SHE:002019 in your portfolio
WheelAI
WheelAI
Analyze SHE:002019 options with the wheel strategy
StockInsider
StockInsider
See market sentiment on SHE:002019